Stay updated with breaking news from Peter Bains. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"Peter, who is a veteran when it comes to the pharma and biopharma industry in terms of his global experience, also understands the Biocon Group because he has basically played a very key role in Syngene. Through Syngene, he has understood the entire Biocon business very well."
Stocks to watch: Shares of firms like HDFC Bank, RR Kabel, Tata Motors, Cipla, Coal India, Biocon, and others will be in focus on Wednesday's trade.
The short build-up was seen in 79 stocks. These included Ipca Laboratories, Delta Corp, SBI Card, NALCO, and Vodafone Idea. An increase in OI along with a fall in price points to a build-up of short positions.
He has over 30 years of global experience in strategic and operational leadership, including at board, CEO and senior corporate levels. He served as CEO and on the Board of Syngene International Ltd, a subsidiary of the company, for almost 6 years from 2010, and led the company to its successful public listing in 2015, Biocon said.
Mazumdar-Shaw said Peter has a unique fit and profile for the role having both extensive global leadership experience and success across the biopharmaceutical field and a comprehensive understanding of the Biocon Group, having led Syngene for 5 years, taking it through its very successful IPO in 2015